Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia

NCT01193283 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

NIH

Sponsor class

Conditions

Aplastic Anemia
Neutropenia
Pancytopenia
Severe Aplastic Anemia

Interventions

DRUG: Cyclophosphamide
DRUG: Cyclosporine

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)